Hilka Rauert-Wunderlich

7PUBLICATIONS
25CO-AUTHORS
Medical mycologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 07, 2026
Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

|Jun 19, 2024
Functional Investigation of IGF1R Mutations in Multiple Myeloma.

Sofia Catalina Heredia-Guerrero, Marietheres Evers, Sarah Keppler

|Nov 17, 2023
Sequential antigen loss and branching evolution in lymphoma after CD19- and CD20-targeted T-cell-redirecting therapy.

Johannes Duell, Alexander M Leipold, Silke Appenzeller

|Dec 31, 2022
CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma.

Viktoria Fuhr, Shanice Heidenreich, Mugdha Srivastava

|Oct 11, 2022
Routine application of the Lymph2Cx assay for the subclassification of aggressive B-cell lymphoma: report of a prospective real-world series.

Alberto Zamò, Elena Gerhard-Hartmann, German Ott

|Aug 11, 2018
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network.

Hilka Rauert-Wunderlich, Anja Mottok, David W Scott

Pageof 2

Frequent Collaborators

2 joint publications

Wolfram Klapper

1 joint publications

Lisa M Rimsza

1 joint publications

German Ott

1 joint publications

Harald Holte